SCOPUS 정보 검색 플랫폼

Volumn 168, Issue 7, 2002, Pages 3275-3282

Intracellular domains of target antigens influence their capacity to trigger antibody-dependent cell-mediated cytotoxicity

(4) Tiroch, Klaus a Stockmeyer, Bernhard a Frank, Carola a Valerius, Thomas a

a UNIVERSITY OF ERLANGEN NUREMBERG (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CD19 ANTIGEN; CHIMERIC PROTEIN; COMPLEMENTARY DNA; HYBRID PROTEIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BURKITT LYMPHOMA; CANCER IMMUNOTHERAPY; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOMA CELL; MONONUCLEAR CELL; NEUTROPHIL; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN DOMAIN; RAJI CELL; TUMOR CELL;

EID: 0036533697 PISSN: 00221767 EISSN: None Source Type: Journal
DOI: 10.4049/jimmunol.168.7.3275 Document Type: Article

Times cited : (25)

References (46)

1
- 0035091343
- Antibody-targeted immunotherapy for treatment of malignancy
- (2001) Annu. Rev. Med. , vol.52 , pp. 125
- White, C.A.¹ Weaver, R.L.² Grillo-Lopez, A.J.³

2
- 0035869407
- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
- (2001) N. Engl. J. Med. , vol.344 , pp. 783
- Slamon, D.J.¹ Leyland-Jones, B.² Shak, S.³ Fuchs, H.⁴ Paton, V.⁵ Bajamonde, A.⁶ Fleming, T.⁷ Eiermann, W.⁸ Wolter, J.⁹ Pegram, M.¹⁰

3
- 0000629542
- Mabthera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large B-cell lymphoma (DLCL): Interim results of a randomized GELA trial
- (2000) Blood , vol.96
- Coiffier, B.¹ Lepage, E.² Herbrecht, R.³ Tilly, H.⁴ Solal-Celigny, P.⁵ Munck, J.N.⁶ Bouabdallah, R.⁷ Lederlin, P.⁸ Sebban, C.⁹ Morel, P.¹⁰

4
- 0033855859
- Clinical trials of antibody therapy
- (2000) Immunol. Today , vol.21 , pp. 403
- Glennie, M.J.¹ Johnson, P.W.²

5
- 0034081614
- Monoclonal antibody therapies: A "constant" threat to cancer
- (2000) Nat. Med. , vol.6 , pp. 373
- Houghton, A.N.¹ Scheinberg, D.A.²

6
- 0031905710
- Fc receptors are required in passive and active immunity to melanoma
- (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 652
- Clynes, R.¹ Takechi, Y.² Moroi, Y.³ Houghton, A.⁴ Ravetch, J.V.⁵

7
- 0034076307
- Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
- (2000) Nat. Med. , vol.6 , pp. 443
- Clynes, R.A.¹ Towers, T.L.² Presta, L.G.³ Ravetch, J.V.⁴

8
- 0027970305
- Monoclonal antibodies as agonists: An expanded role for their use in cancer therapy
- (1994) Cancer Res. , vol.54 , pp. 5301
- Vitetta, E.S.¹ Uhr, J.W.²

9
- 0032530929
- Monoclonal antibody therapy of B cell lymphoma: Signaling activity on tumor cells appears more important than recruitment of effectors
- (1998) J. Immunol. , vol.161 , pp. 3176
- Tutt, A.L.¹ French, R.R.² Illidge, T.M.³ Honeychurch, J.⁴ McBride, H.M.⁵ Penfold, C.A.⁶ Fearon, D.T.⁷ Parkhouse, R.M.⁸ Klaus, G.G.⁹ Glennie, M.J.¹⁰

10
- 0028127935
- Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of bcl-2 protein
- (1994) Blood , vol.83 , pp. 899
- Vuist, W.M.¹ Levy, R.² Maloney, D.G.³

11
- 0034613151
- Immune inhibitory receptors
- (2000) Science , vol.290 , pp. 84
- Ravetch, J.V.¹ Lanier, L.L.²

12
- 0034668385
- Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma
- (2000) Blood , vol.96 , pp. 3544
- Honeychurch, J.¹ Tutt, A.L.² Valerius, T.³ Heijnen, I.A.⁴ Van de Winkel, J.G.⁵ Glennie, M.J.⁶

13
- 85037018204
- MAC-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma
- A. B. van Spriel, ed. Doctoral thesis, University of Utrecht, Utrecht, The Netherlands
- (2001) Neutrophil Fc Receptors and Mac-1: From Biology to Immunology , pp. 65
- Van Spriel, A.B.¹ Van Oijk, H.H.² Bakker, A.³ Jansen, M.J.H.⁴ Van de Winkel, J.G.⁵

14
- 0345365618
- HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor
- (1996) Blood , vol.87 , pp. 3803
- Elsässer, D.¹ Valerius, T.² Repp, R.³ Weiner, G.J.⁴ Deo, Y.⁵ Kalden, J.R.⁶ Van de Winkel, J.G.⁷ Stevenson, G.T.⁸ Glennie, M.J.⁹ Gramatzki, M.¹⁰

15
- 2642651103
- Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells
- (1998) Cancer Res. , vol.58 , pp. 3051
- Würflein, D.¹ Dechant, M.² Stockmeyer, B.³ Tutt, A.L.⁴ Hu, P.⁵ Repp, R.⁶ Kalden, J.R.⁷ Van de Winkel, J.G.⁸ Epstein, A.L.⁹ Valerius, T.¹⁰

16
- 0034670004
- Triggering FcαRI (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy
- (2000) J. Immunol. , vol.165 , pp. 5954
- Stockmeyer, B.¹ Dechant, M.² Van Egmond, M.³ Tutt, A.L.⁴ Sundarapandiyan, K.⁵ Graziano, R.F.⁶ Repp, R.⁷ Kalden, J.R.⁸ Gramatzki, M.⁹ Glennie, M.J.¹⁰

17
- 0035800515
- Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: Stimulation by GM-CSF and role of Fcγ-receptors
- (2001) Br. J. Cancer , vol.85 , pp. 463
- Ottonello, L.¹ Epstein, A.L.² Mancini, M.³ Tortolina, G.⁴ Dapino, P.⁵ Dallegri, F.⁶

18
- 0031053094
- Preclinical studies with FcγR bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer
- (1997) Cancer Res. , vol.57 , pp. 696
- Stockmeyer, B.¹ Valerius, T.² Repp, R.³ Heijnen, I.A.⁴ Buhring, H.J.⁵ Deo, Y.M.⁶ Kalden, J.R.⁷ Gramatzki, M.⁸ Van de Winkel, J.G.⁹

19
- 85037009658
- EGF-R and G250: Useful target antigens for antibody-mediated cellular cytotoxicity against renal cell carcinoma?
- In press
- J. Urol.
- Stadick, H.¹ Stockmeyer, B.² Kühn, R.³ Schrott, K.M.⁴ Kalden, J.R.⁵ Glennie, M.J.⁶ Van de Winkel, J.G.⁷ Gramatzki, M.⁸ Valerius, T.⁹ Elsässer, D.¹⁰

20
- 0025343230
- Signal transduction by receptors with tyrosine kinase activity
- (1990) Cell , vol.61 , pp. 203
- Ullrich, A.¹ Schlessinger, J.²

21
- 0034600849
- The ErbB signaling network: Receptor heterodimerization in development and cancer
- (2000) EMBO J. , vol.19 , pp. 3159
- Olayioye, M.A.¹ Neve, R.M.² Lane, H.A.³ Hynes, N.E.⁴

22
- 0024337144
- Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
- (1989) Science , vol.244 , pp. 707
- Slamon, D.J.¹ Godolphin, W.² Jones, L.A.³ Holt, J.A.⁴ Wong, S.G.⁵ Keith, D.E.⁶ Levin, W.J.⁷ Stuart, S.G.⁸ Udove, J.⁹ Ullrich, A.¹⁰ Press, M.F.¹¹

23
- 0030944455
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
- (1997) EMBO J. , vol.16 , pp. 1647
- Graus-Porta, D.¹ Beerli, R.R.² Daly, J.M.³ Hynes, N.E.⁴

24
- 0032851961
- Nonclinical studies addressing the mechanism of action of trastuzumab (herceptin)
- (1999) Semin. Oncol. , vol.26 , pp. 60
- Sliwkowski, M.X.¹ Lofgren, J.A.² Lewis, G.D.³ Hotaling, T.E.⁴ Fendly, B.M.⁵ Fox, J.A.⁶

25
- 0030901968
- The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity
- (1997) Immunity , vol.6 , pp. 107
- Tedder, T.F.¹ Inaoki, M.² Sato, S.³

26
- 0034097043
- Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
- (2000) Anna. Rev. Immunol. , vol.18 , pp. 393
- Fearon, D.T.¹ Carroll, M.C.²

27
- 0029064680
- Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice
- (1995) Nature , vol.376 , pp. 352
- Rickert, R.C.¹ Rajewsky, K.² Roes, J.³

28
- 0029094609
- Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
- (1995) Immunity , vol.3 , pp. 39
- Engel, P.¹ Zhou, L.J.² Ord, D.C.³ Sato, S.⁴ Koller, B.⁵ Tedder, T.F.⁶

29
- 0030588569
- CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity
- (1996) J. Immunol. , vol.157 , pp. 4371
- Sato, S.¹ Ono, N.² Steeber, D.A.³ Pisetsky, D.S.⁴ Tedder, T.F.⁵

30
- 0000097822
- 3 antibody derivates
- G. Gallagher, R. C. Rees, and C. W. Reynolds, eds. Oxford University Press, Oxford
- (1995) Tumor Immunobiology: A Practical Approach , pp. 225
- Glennie, M.J.¹ Tutt, A.L.² Greenman, J.³

31
- 0024368864
- Precise gene fusion by PCR
- (1989) Nucleic Acids Res. , vol.17 , pp. 4895
- Yon, J.¹ Fried, M.²

32
- 0035251734
- Mechanisms of G-CSF- or GMCSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies
- (2001) J. Immunol. Methods , vol.248 , pp. 103
- Stockmeyer, B.¹ Elsässer, D.² Dechant, M.³ Repp, R.⁴ Gramatzki, M.⁵ Glennie, M.J.⁶ Van de Winkel, J.G.⁷ Valerius, T.⁸

33
- 0032826180
- Signaling antibodies in cancer therapy
- (1999) Curr. Opin. Immunol. , vol.11 , pp. 541
- Cragg, M.S.¹ French, R.R.² Glennie, M.J.³

34
- 0028174946
- Fcγ receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody
- (1994) Blood , vol.83 , pp. 1632
- Vervoordeldonk, S.F.¹ Merle, P.A.² Van Leeuwen, E.F.³ Van der Schoot, C.E.⁴ Von dem Borne, A.E.⁵ Slaper-Cortenbach, I.C.⁶

35
- 0026692781
- Radiolabeled antibody targeting of the HER-2/neu oncoprotein
- (1992) Cancer Res. , vol.52 , pp. 1916
- De Santes, K.¹ Slamon, D.² Anderson, S.K.³ Shepard, M.⁴ Fendly, B.⁵ Maneval, D.⁶ Press, O.⁷

36
- 0034955304
- Floating the raft hypothesis: Lipid rafts play a role in immune cell activation
- (2001) Immunity , vol.14 , pp. 657
- Cherukuri, A.¹ Dykstra, M.² Pierce, S.K.³

37
- 0035963274
- Heregulin-dependent translocation and hyperphosphorylation of ErbB-2
- (2001) Oncogene , vol.20 , pp. 3918
- Zhou, W.¹ Carpenter, G.²

38
- 0035059418
- The immunological synapse
- (2001) Annu. Rev. Immunol. , vol.19 , pp. 375
- Bromley, S.K.¹ Burack, W.R.² Johnson, K.G.³ Somersalo, K.⁴ Sims, T.N.⁵ Sumen, C.⁶ Davis, M.M.⁷ Shaw, A.S.⁸ Allen, P.M.⁹ Dustin, M.L.¹⁰

39
- 0033593045
- The human natural killer cell immune synapse
- (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 15062
- Davis, D.M.¹ Chiu, I.² Fassett, M.³ Cohen, G.B.⁴ Mandelboim, O.⁵ Strominger, J.L.⁶

40
- 0035871884
- Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation
- (2001) Blood , vol.97 , pp. 2478
- Van Spriel, A.B.¹ Leusen, J.H.² Van Egmond, M.³ Dijkman, H.B.⁴ Assmann, K.J.⁵ Mayadas, T.N.⁶ Van de Winkel, J.G.⁷

41
- 0034232037
- The immunological synapse and the actin cytoskeleton: Molecular hardware for T cell signaling
- (2000) Nat. Immunol. , vol.1 , pp. 23
- Dustin, M.L.¹ Cooper, J.A.²

42
- 0001544548
- Rituximab: Correlation between effector cells and clinical activity in NHL
- (1998) Blood , vol.92
- Janakiraman, N.¹ McLaughlin, P.² White, C.A.³ Maloney, D.G.⁴ Shen, D.⁵ Grillo-Lopez, A.J.⁶

43
- 0035863830
- The intriguing role of polymorphonuclear neutrophils in antitumor reactions
- (2001) Blood , vol.97 , pp. 339
- Di Carlo, E.¹ Forni, G.² Lollini, P.³ Colombo, M.P.⁴ Modesti, A.⁵ Musiani, P.⁶

44
- 0028852564
- Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model
- (1995) Cancer Res. , vol.55 , pp. 840
- Hooijberg, E.¹ Van den Berk, P.C.² Sein, J.J.³ Wijdenes, J.⁴ Hart, A.A.⁵ De Boer, R.W.⁶ Melief, C.J.⁷ Hekman, A.⁸

45
- 0030806221
- Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells
- (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 7509
- Ghetie, M.A.¹ Podar, E.M.² Ilgen, A.³ Gordon, B.E.⁴ Uhr, J.W.⁵ Vitetta, E.S.⁶

46
- 0035112172
- Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy
- (2001) Crit. Rev. Oncol. Hematol. , vol.38 , pp. 47
- Van Ojik, H.H.¹ Valerius, T.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.